Determines clonality in lymphoproliferative disorders by analyzing gene sequences.
B-cell immunoglobulin heavy chain (IgH) gene rearrangements
This test is for the IgH gene rearrangements (FR1, FR2 and FR3) and will detect greater than 80% of B-cell lymphoproliferative disorders.
T-cell Receptor (beta and gamma) gene rearrangements:
This test is for detecting monoclonality of T lymphocytes using primers targeted at both beta and gamma gene rearrangements, and will detect at least 90% of T-cell lymphoproliferative disorders.
Bcl-2
This test is specific for the major breakpoint region (mbr) of the bcl-2 associated translocation [t(14;18)]. This translocation is associated with up to 85% of lymphomas with a follicular morphology, and with approximately one third of diffuse large cell lymphomas.
Bcl-1
This test is specific for the translocation involving the Cyclin D1 gene [t(11;14)]. It is commonly associated with Mantle Cell Lymphoma (MCL).
T &/or B cell rearrangement
To determine clonality in lymphoproliferative disorders
IGH
Conventional PCR and fragment analysis
2 weeks
No
B Cell gene rearrangement: $130
T Cell gene rearrangement: $180
Standard business unit request form
Blood or bone marrow or Lymph node or Tumour
None